Market Place
Sourcing Support
Rapport Therapeutics Hosts Investor and Analyst Day; Updates
02 Jun 2025 //
GLOBENEWSWIRE
Rapport Therapeutics at Jefferies and Goldman Sachs Conferences
27 May 2025 //
GLOBENEWSWIRE
Rapport Therapeutics to Host 2025 Investor and Analyst Day
21 May 2025 //
GLOBENEWSWIRE
Rapport Therapeutics Reports Q1 2025 Financials and Update
08 May 2025 //
GLOBENEWSWIRE
Rapport Therapeutics to Join Investor Conferences
22 Apr 2025 //
GLOBENEWSWIRE
Rapport Therapeutics to Present Data at 2025 AAN Annual Meeting
21 Mar 2025 //
GLOBENEWSWIRE
Rapport Therapeutics Reports Q4 and Full Year 2024 Results
11 Mar 2025 //
GLOBENEWSWIRE
Rapport Names Dr. Jeffrey Sevigny As Chief Medical Officer
03 Mar 2025 //
GLOBENEWSWIRE
Rapport Therapeutic to Participate in Upcoming Investor Conferences
24 Feb 2025 //
GLOBENEWSWIRE
Rapport Therapeutics Highlights RAP-219 Data for CNS Disorders
09 Jan 2025 //
GLOBENEWSWIRE
Rapport Therapeutics Shares Ph 1 Data on RAP-219 for CNS Disorders
09 Jan 2025 //
GLOBENEWSWIRE
Rapport: RNS Decreases Link to Clinical Seizure Reductions
06 Dec 2024 //
GLOBENEWSWIRE
Rapport Therapeutics to Present at Epilepsy Society Meeting
14 Nov 2024 //
GLOBENEWSWIRE
FDA places Rapport`s nerve damage trial on hold
08 Nov 2024 //
FIERCE BIOTECH
Rapport Therapeutics Reports Q3 Financials & Business Update
07 Nov 2024 //
GLOBENEWSWIRE
Rapport Therapeutics to Present at Stifel & Jefferies Conferences
04 Nov 2024 //
GLOBENEWSWIRE
Rapport Therapeutics To Present At Epilepsy Conferences
05 Sep 2024 //
GLOBENEWSWIRE
Rapport Therapeutics to Present at Morgan Stanley Conference and TD Cowen Summit
29 Aug 2024 //
GLOBENEWSWIRE
Rapport Therapeutics Reports Q2 Financials And Business Update
08 Aug 2024 //
GLOBENEWSWIRE
Rapport To Present TARP?8 AMPAR Data At IASP 2024 Congress
29 Jul 2024 //
GLOBENEWSWIRE
Rapport Closes $174M IPO With Full Overallotment, Private Placement
12 Jun 2024 //
GLOBENEWSWIRE
Rapport upsizes IPO, tacking on $32M
07 Jun 2024 //
FIERCE BIOTECH
Rapport Therapeutics Announces Pricing of Initial Public Offering
06 Jun 2024 //
GLOBENEWSWIRE
Rapport, a clinical-stage neuroscience biotech, files for IPO
17 May 2024 //
ENDPTS
J&J-backed startup Rapport files for US IPO
17 May 2024 //
REUTERS
Rapport Therapeutics Appoints Pioneering Industry Leader John Maraganore
19 Mar 2024 //
BUSINESSWIRE
Rapport Therapeutics Appoints Terry-Ann Burrell to Board of Directors
16 Jan 2024 //
BUSINESSWIRE
Rapport to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
BUSINESSWIRE
Rapport Therapeutics Appoints Chief Financial Officer
30 Oct 2023 //
BUSINESSWIRE
Rapport Appoints Chief Operating Officer and Scientific Advisory Board Member
07 Sep 2023 //
BUSINESSWIRE
